Events By Category | Events By Hotbed | Event News | Search Events
Event Nameexl pharma 2017 4th Rx-to-OTC Switch Summit
Event Date(s) Monday, December 04, 2017  to Tuesday, December 05, 2017
Event Location TBD
Philadelphia, Pennsylvania
Cost$1,795 - $2,395
DescriptionSwitching drugs from prescription (Rx) to over-the-counter (OTC) status is a commercial strategy that has been growing in popularity. More than 20 products have been switched over to OTC during the past decade — and there has been a plethora of high-profile switch failures and disappointing results. Successful switches are as much an art as a science, and it has become increasingly apparent that switch teams must revise their best practices in strategy, marketing, sales, clinical research, regulatory affairs, medical writing, labeling and packaging if they are to effectively collaborate and lead an Rx product through the switch to OTC.

Now in its fourth consecutive year, ExL’s Rx-to-OTC Switch Summit is the most advanced thought leadership event experts can attend to discuss all aspects of a switch, from the NDA process to the final over-the-counter product; analyze current trends; and prepare for future switches. Whether you are exploring your chances of tapping into the very lucrative OTC marketplace or are an expert in the field, this conference will provide detailed presentations, intensive case studies and collaborative panel discussions relevant to your interests, maximizing the learning experience for overcoming the shared challenges of the industry. In addition, designated lunches and networking breaks will enhance the exchange of knowledge and foster future business partnerships.

Top Five Reasons to Attend

• Explore current trends and business models, and identify how to lead your Rx drug through the OTC switch journey
• Review the latest switches and learn from examples of successful and failed switches, as well as what caused their outcomes
• Hear how industry stakeholders can work together with key stakeholders — such as the FDA, retailers and government agencies — on the switch process and discuss the latest regulatory challenges and initiatives, including NSURE
• Understand the future of Rx-to-OTC switches and stay up to date with commercial strategies
• Network with leading industry professionals to exchange best practices for ensuring a seamless Rx-to-OTC switch, and brainstorm new marketing and branding strategies

Who Should Attend

This conference is designed for professionals from pharmaceutical companies with responsibilities in the following areas:

• Rx-to-OTC Switches
• Consumer Healthcare Products
• Marketing/Brand Management/Product Management
• Regulatory Affairs/Regulatory Processes
• Clinical Development
• Legal Affairs/Counsel/Regulatory Counsel
• Medical/Scientific Affairs
• Clinical Trials
• Research and Development
• Business Strategy
• Labeling/Packaging • Drug Delivery Technology • Product Development • Corporate Development This event is also of interest to: • Strategy and Marketing Consultants • Clinical Research Labs • CROs/CMOs • Drug After-Market Manufacturers/Suppliers • Legal/Regulatory Advisors • Statistical Service Providers • Marketing Organizations
SponsorRebound Therapeutics
Host CompanyRebound Therapeutics
Contact Information Phone: 866-207-6528
Fax:   888-221-6750 
More Information